Discover Great Companies Discover Great Clients
Companies Salaries Jobs
Jobs |
Jobs Companies Salary Majors

Company Overview

Development Stage

About the Company

浙江瑞博制药有限公司系浙江九洲药业股份有限公司(股票代码603456)全资子公司,以满足客户需求为导向,致力于为客户提供一站式医药研发和生产服务。服务涉及原料药、医药中间体、创新药小分子化合物的工艺开发、工艺优化、商业化生产、质量属性研究、质量风险评估、分析方法开发、标准品和杂质谱的建立等。 瑞博制药占地约120000平方米,现有员工1500人,拥有350多人的实力雄厚、多领域、国际化的高层次人才的研发团队,其中硕博以上学历85人。公司已多次通过FDA、EDQM、PMDA、cFDA、ANVISA、COFEPRIS等官方审计。

通过多年来的潜心研究,瑞博制药占据国际制药技术的制高点,目前在世界主流制药工艺和手段上已与跨国制药企业出色衔接。公司正快速成长为从事合同研发与合同定制业务的知名企业。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (17 open positions)

Manage
Note: How fast is hiring at 浙江瑞博制药有限公司 growing? 2025年5个(下降85%),2024年33个(下降56%),2023年75个(增长97%),2022年38个(增长1167%),2021年3个. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2024 — 9 fewer jobs than 2023
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 浙江瑞博制药有限公司 growing? 历年硕士招聘职位量:2024年1个(下降56%),2023年10个(增长97%),2022年2个(增长1167%).

Doctoral Degree Job Demand Analysis

(More)
N/A
Growth Rate
Doctoral Hiring by Year: 2023 — 5 more jobs than 2022
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 浙江瑞博制药有限公司 growing? 历年博士招聘职位量:2023年6个(增长97%),2022年1个(增长1167%).

— What Are the Salaries Like? (27 records)

Manage
salary range: 6K - 50K, 66.6% of roles pay ¥8-20K
Note: salary statistics are based on 27 salary records from the past year and depend on the job sample. For reference only.
浙江瑞博制药有限公司工资待遇怎么样?66.6%的岗位拿8-20K,本科工资¥。台州地区工资排名前15%,与同行业比+44%,工厂生产类平均工资¥19.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 浙江瑞博制药有限公司? We provide: ehs,qc,副主任,qa,合规,工程部副经理,车间,项目负责人,安全,实验室经理,工艺工程,操作工,生产技术,设备员,设备工. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 工厂生产类
    48.1% of total 48.1%
  • 经营管理类
    33.3% of total 33.3%
  • 技工类
    29.6% of total 29.6%
  • 质量管理类
    22.2% of total 22.2%

Education

  • 本科
    74.1% of total 74.1%
  • 大专
    22.2% of total 22.2%
  • 高中
    3.7% of total 3.7%

Experience

  • 5-10年
    51.9% of total 51.9%
  • 1-3年
    18.5% of total 18.5%
  • 3-5年
    14.8% of total 14.8%
  • 不限
    14.8% of total 14.8%
View Detailed Analysis

What does 浙江瑞博制药有限公司 require? Who is 浙江瑞博制药有限公司 hiring? 招聘类别工厂生产类占比最多占48.1%,其次是经营管理类占33.3%。什么学历能进?本科占比最多占74.1%,其次是大专占22.2%。工作经验有什么要求?5-10年占比最多占51.9%,其次是1-3年占18.5%。工作地区在哪?台州占比最多占100%。 Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 31,100万(元)
Legal Representative: 陈东霞
Date Established:
Credit Code: 91331082MA28GD0X05
Registered Address: 浙江省化学原料药基地临海园区南洋三路18号

Partners & Suppliers

浙江瑞博制药为艾伯维提供CDMO服务。 Source
合作客户 合同定制研发生产(CDMO)
浙江瑞博制药为吉利德提供抗病毒药物中间体的定制研发生产服务。 Source
合作客户 合同定制研发生产(CDMO)
浙江瑞博制药为罗氏提供CDMO服务,包括原料药工艺开发和生产。 Source
合作客户 合同定制研发生产(CDMO)
浙江瑞博制药作为九洲药业子公司,为诺华提供原料药及中间体的合同定制研发生产服务。 Source
合作客户 合同定制研发生产(CDMO)
浙江瑞博制药为默沙东提供合同定制研发生产服务。 Source
合作客户 合同定制研发生产(CDMO)

People who follow this company also follow

Competitors (Similar Companies)

医药 制药 制药/药业 医药原料
制药/药业 医药 制药 医药中间体
“海纳厚生、正道修远”
“主要从事抗生毒、中成药、化学合成药、基因工程药品的生产销售,以及中西药、中药材、医疗器械等的批零经销”
“一家产品集医药制剂和原料药为一体的制药企业”
“中国医药工业化药百强”
“开发基于RNA干扰(RNAi)技术的核酸药物”
医药 制药 原料药 医药原料
“是一家镀金、镀镍、镀钯镍、镀纯亮锡、镀纯雾锡等产品”
医药 制药/药业 原料药 健康科技
医药流通 新特药 大健康 心血管药
“秉承科学、极致的企业文化,致力于为世界范围内的患者提供优质的产品和服务”
制药/药业 原料药 头孢曲松钠
“成为女性健康领域标杆企业,成为中药衍生领域品牌企业”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates

文玩收藏
客服
由百度提供